PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.11%
Negative net income growth while MRVL stands at 62.42%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-8.63%
Negative yoy D&A while MRVL is 2.21%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-331.25%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-59.60%
Negative yoy SBC while MRVL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
336.79%
Well above MRVL's 93.08% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
143.06%
AR growth of 143.06% while MRVL is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
8.02%
Some inventory rise while MRVL is negative at -5.59%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
188.76%
AP growth of 188.76% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
59.50%
Lower 'other working capital' growth vs. MRVL's 152.00%. David Dodd would see fewer unexpected short-term demands on cash.
-19.83%
Both negative yoy, with MRVL at -61.41%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
33.03%
Operating cash flow growth below 50% of MRVL's 692.07%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
50.29%
CapEx growth well above MRVL's 14.00%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Acquisition spending well above MRVL's 99.84%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-542.02%
Negative yoy purchasing while MRVL stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
167.39%
Proceeds from sales/maturities above 1.5x MRVL's 1.12%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
100.00%
Growth of 100.00% while MRVL is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
75.51%
Investing outflow well above MRVL's 77.20%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-33.72%
Both yoy lines negative, with MRVL at -100.00%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-25.00%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.